Therapeutic trial of simvastatin versus fenofibrate in primary hypercholesterolemia
Turki, S.; Mekaouer, A.; Kaabachi, A.; Ftouhi, B.; Mebazaa, R.; Ben Khalifa, F.
La Tunisie Medicale 72(11): 619-624
1994
ISSN/ISBN: 0041-4131 PMID: 7762089 Document Number: 437063
Document emailed within 1 workday
Related Documents
Fricker, J.; Douste-Blazy, P.; Drouin, P.; De Gennes, J.L.; Dachet, C.; Keller, U. 1990: The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia Presse Medicale 19(42): 1927-1930Riesen, W.F.; Keller, U.; Del Bufalo, A.; Reutter, F.W.; Baur, H.R.; Golay, A.; Bertel, O.; Kummer, H.; Kistler, H.; Ammann, F. 1989: Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(48): 1719-1723
Leclercq, V.; Harvengt, C. 1989: Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial International Journal of Clinical Pharmacology Therapy and Toxicology 27(2): 76-81
Lambrecht, L.J.; Malini, P.L. 1993: Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group Acta Cardiologica 48(6): 541-554
Kowalski, J.; Okopien, B.; Madej, A.; Zielinski, M.; Belowski, D.; Kalina, Z.; Herman, Z.S. 2003: Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia International Journal of Clinical Pharmacology and Therapeutics 41(6): 241-247
Bo, M.; Nicolello, M.T.; Fiandra, U.; Mercadante, G.; Piliego, T.; Fabris, F. 2001: Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin Nutrition Metabolism and Cardiovascular Diseases: Nmcd 11(1): 17-24
Deslypere, J.P. 1989: Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia Acta Cardiologica 44(5): 379-388
Stein, E.; Kreisberg, R.; Miller, V.; Mantell, G.; Washington, L.; Shapiro, D.R. 1990: Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group i Archives of Internal Medicine 150(2): 341-345
Giannini, S.D.; de Góes, J.M.; Dereviack, B.E.; Machado, C.; Forti, N.; Diament, J. 1990: Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis Arquivos Brasileiros de Cardiologia 54(6): 407-414
Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. 2011: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia International Angiology: a Journal of the International Union of Angiology 30(3): 295; Author Reply 296
Ludmila G. Vladimirova-Kitova; Deneva, T.I. 2010: Simvastatin and Asymmetric Dimethylarginine-Homocysteine Metabolic Pathways in Patients with Newly Detected Severe Hypercholesterolemia Clinical Laboratory 56(7-8): 291-302
Tomei, R.; Rossi, L.; Carbonieri, E.; Franceschini, L.; Cemin, C.; Ghebremariam-Tesfau, K.; Zardini, P. 1993: Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia Cardiologia 38(12): 773-778
Vladimirova-Kitova, L.G.; Deneva, T.I.; Nikolov, F.P. 2011: Effect of moderate and high dose simvastatin on adhesion molecules in severe hypercholesterolemia after targeting the LDL-cholesterol--a randomised, placebo-controlled study Folia Medica 53(2): 13-21
Stefanutti, C.; Lucani, G.; Vivenzio, A.; Di Giacomo, S. 1999: Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood Drugs under Experimental and Clinical Research 25(1): 23-28
Fedele, F. 2003: DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. a multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine La Clinica Terapeutica 154(4): 231-236
Martínez-Abundis, E.; Barrera-Durán, C.; González-Ortiz, M.; Hernández-Salazar, E. 2016: Effect of simvastatin plus inulin in comparison with simvastatin plus ezetimibe on the treatment of mixed dyslipidemia Gaceta Medica de Mexico 152(Suppl 2): 88-95
McKenney, J.; Ballantyne, C.M.; Feldman, T.A.; Brady, W.E.; Shah, A.; Davies, M.J.; Palmisano, J.; Mitchel, Y.B. 2005: LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD Medgenmed: Medscape General Medicine 7(3): 3
Manojlović, D.; Lepsanović, L.; Micić, D.; Sumarac, M.; Kendereski, L.; Popović, V.; Mićić, J. 1991: Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia Srpski Arhiv Za Celokupno Lekarstvo 119(1-2): 22-25
Teo, K.K.; Burton, J.R.; Buller, C.; Plante, S.; Yokoyama, S.; Montague, T.J. 1997: Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators Canadian Journal of Cardiology 13(6): 591-599
Smith, D.H.; Neutel, J.M.; Jankelow, D.; Myburgh, D.P. 1990: Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia South African Medical Journal 77(10): 500-503